133 related articles for article (PubMed ID: 2233400)
1. Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron.
Mayberry-Carson KJ; Tober-Meyer B; Gill LR; Lambe DW; Hossler FE
Microbios; 1990; 64(258):49-66. PubMed ID: 2233400
[TBL] [Abstract][Full Text] [Related]
2. Osteomyelitis experimentally induced with Bacteroides thetaiotaomicron and Staphylococcus epidermidis. Influence of a foreign-body implant.
Mayberry-Carson KJ; Tober-Meyer B; Lambe DW; Costerton JW
Clin Orthop Relat Res; 1992 Jul; (280):289-99. PubMed ID: 1611759
[TBL] [Abstract][Full Text] [Related]
3. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits.
Lambe DW; Ferguson KP; Mayberry-Carson KJ; Tober-Meyer B; Costerton JW
Clin Orthop Relat Res; 1991 May; (266):285-94. PubMed ID: 2019061
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin concentrations in serum, bone and bone marrow of rabbits.
Gill LR; Mayberry-Carson KJ; Tober-Meyer B; Hodin F; Lambe DW; Painter BG
Microbios; 1989; 58(235):113-26. PubMed ID: 2739588
[TBL] [Abstract][Full Text] [Related]
5. An electron microscopic study of the effect of clindamycin therapy on bacterial adherence and glycocalyx formation in experimental Staphylococcus aureus osteomyelitis.
Mayberry-Carson KJ; Tober-Meyer B; Lambe DW; Costerton JW
Microbios; 1986; 48(196-197):189-206. PubMed ID: 3796304
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
[TBL] [Abstract][Full Text] [Related]
7. Effect of ciprofloxacin on subcutaneous abscesses induced with Staphylococcus epidermidis and a foreign body implant in the mouse.
Mayberry-Carson KJ; Tober-Meyer B; Gill LR; Lambe DW; Mayberry WR
Microbios; 1988; 54(218):45-59. PubMed ID: 3173128
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of vertebral osteomyelitis with recombinant human bone morphogenetic protein-2.
O'Shaughnessy BA; Kuklo TR; Ondra SL
Spine (Phila Pa 1976); 2008 Mar; 33(5):E132-9. PubMed ID: 18317180
[TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental osteomyelitis by liposomal antibiotics.
Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
[TBL] [Abstract][Full Text] [Related]
12. Synergism between Bacteroides fragilis and Staphylococcus aureus in experimental tibial osteomyelitis.
Rissing JP; Buxton TB; Horner JA; Shockley RK; Fisher JF; Harris R
J Lab Clin Med; 1987 Oct; 110(4):433-8. PubMed ID: 3655522
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
[TBL] [Abstract][Full Text] [Related]
16. Local administration of antibiotics with an implantable osmotic pump.
Perry CR; Rice S; Ritterbusch JK; Burdge RE
Clin Orthop Relat Res; 1985; (192):284-90. PubMed ID: 3967435
[TBL] [Abstract][Full Text] [Related]
17. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
Mader JT; Morrison LT; Adams KR
Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251
[TBL] [Abstract][Full Text] [Related]
19. Activity of ciprofloxacin in the treatment of experimental intra-abdominal abscesses in mice.
Esposito S
Clin Ther; 1989; 11(1):32-7. PubMed ID: 2720726
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Sande MA; Brooks-Fournier RA; Gerberding JL
Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
